EditorialEditorial
Randomized Controlled Trials Are Not Appropriate for Imaging Technology Evaluation
Peter E. Valk
Journal of Nuclear Medicine July 2000, 41 (7) 1125-1126;


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Randomized Controlled Trials Are Not Appropriate for Imaging Technology Evaluation
Peter E. Valk
Journal of Nuclear Medicine Jul 2000, 41 (7) 1125-1126;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Impact of 18F-FET PET/MRI on Clinical Management of Brain Tumor Patients
- Evaluation of the Efficacy of Targeted Imaging Agents
- Randomized Controlled Trials on PET: A Systematic Review of Topics, Design, and Quality
- Clinical research and diagnostic efficacy studies in the oral and maxillofacial radiology literature: 1996-2005
- 18F-FDG PET in Candidates for Radiation Therapy: Is It Important and How Do We Validate Its Impact?
- 18F-FDG PET Provides High-Impact and Powerful Prognostic Stratification in Staging Newly Diagnosed Non-Small Cell Lung Cancer
- 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer